🌍 Exciting news! The Government of Flanders (@vlaamseoverheid) has allocated €2⃣ million to boost health security in #Africa with MPP & @WHO.
✅This is to strengthen local #vaccine and #therapeutic manufacturing for better #pandemic preparedness.
🔗https://t.co/psYZlVQb0l
#GlobalHealth #HealthEquity #Flanders
🏭Delighted to be attending 2nd African Manufacturing Forum for AU Member States in #Cairo🇪🇬. We fully support regional manufacturing of vaccines & therapeutics on the continent 💉 @gavi@AfricaCDC@CharlieGore#vaccines#AccessToHealth
🌍🎗️ This #WorldCancerDay, be inspired by Kennedy Odhiambo's journey in #Kenya 🇰🇪through #NasopharyngealCancer.
🗣️His story highlights the urgent need for accessible and affordable cancer treatments.
📑Read how Kennedy's determination and community support helped him overcome immense challenges.
📖✨https://t.co/hU5rkjkBCZ
#CancerAwareness #NasopharyngealCancer #HealthForAll #UnitedByUnique
🌍🎗️ This #WorldCancerDay, join us in raising awareness about #ChronicMyeloidLeukaemia and the importance of accessible treatments.
📹Watch our exclusive interview with Prof. Zeba Aziz as she discusses the impact of #nilotinib and the efforts to make life-saving medicines available to all.
📺✨Don't miss out!
🔗https://t.co/kFGoxNsWkX
#CancerAwareness #HealthForAll #UnitedByUnique
🌟 New Video Alert ahead of #WorldChildrensDay ! 🌟
💻Discover the story of the Nyumbani Children's Home, a sanctuary for babies and children with #HIV in #Kenya🇰🇪. Nyumbani, meaning "home" in #Kiswahili, has transformed from a hospice into a loving home for approximately 1⃣0⃣0⃣ orphans and vulnerable children.
📽️In this video, we explore the incredible advancements in paediatric HIV medicines, making it easier to provide care for these young ones.
🤓Learn about the upcoming rollout of paediatric #ALD, a fixed-dose combination for children living with HIV, and see firsthand the impact of access to adapted paediatric formulations in LMICs.
@NyumbaniUSA@GAP_f_Network #BetterMeds4Kids
🔗https://t.co/NwIuvEk6io
💉New advancements to prevent #RSV infection bring hope on this #WorldPneumoniaDay ✨ !
💪🏽Maternal vaccination and monoclonal antibodies like #nirsevimab and #clesrovimab offer promising protection against RSV.
🇺🇳@WHO’s SAGE recommended that all countries introduce passive immunisation for the prevention of severe RSV disease in young infants👶🏽🐣.
✨At MPP, we believe in the power of voluntary licensing and technology transfer to make life-saving RSV therapies accessible and affordable especially in low- and middle-income countries🌍 where the massive burden of RSV is concentrated.
➡️Read the message from MPP Executive Director @CharlieGore and spread the word!
🔗 https://t.co/eyxEi8xMiR
@Stop_Pneumonia @wellcometrust@IAVI@unitaid@ReSViNET #BetterMeds4Kids #RSVPrevention #GlobalHealth
📢On this #WorldHepatitisDay, let's amplify the urgent message from @CharlieGore: The fight against #hepatitis is at a critical juncture. Despite having the tools to prevent and treat hepatitis B and C, mortality rates are rising, and we are veering off course from the 2030 target.
✊🏽It's #TimeForAction, not complacency.
Read his message > https://t.co/tPCap2MZeD
📸 A big shout-out to everyone who visited our MPP/@UNITAID booth (#904) at #AIDS2024! Your support for the #IAmPartOfTheDTGStory campaign has been overwhelming. 🥰
There's still time to be part of the story! Come get your photo taken and join the movement. Together, we're making history. 🌍✨
https://t.co/rYbkibfGXY
#GlobalHealth #MakeADifference #DTGDecade
"We need to grant generic licensing through the UN backed Medicines Patent Pool, and make generics available for all of Africa, Asia and Latin America." - @UNAIDS Executive Director @Winnie_Byanyima 🇺🇳 #AIDS2024
🥰MPP is excited to be #AIDS2024👇
✅ Our team is speaking in a number of sessions of the official programme
✅ We are also participating in many events organised in the Exhibition Area and at the Global Village
✅ MPP & @UNITAID are teaming up at booth #904 in the Exhibition Area. Come and meet us there!
Check out MPP full programme 👉 https://t.co/7BlNKZNVht
We're excited to be at #AIDS2024 in a few days! 🎉
✅Our team will be speaking in a number of sessions of the official programme
✅We will also participate in many events organised in the Exhibition Area and at the Global Village
✅MPP & @UNITAID are teaming up at booth #904 in the Exhibition Area. Come and meet us there!
Check out MPP full programme at #AIDS2024 👉🏽https://t.co/7BlNKZNVht
Following the MPP-ViiV agreement on #dolutegravir in late 2020, we're pleased to announce progress in the fight against #HIV in Azerbaijan🇦🇿, Belarus🇧🇾, Kazakhstan🇰🇿 & Malaysia🇲🇾👇
✅ In Belarus & Kazakhstan, the volumes of DTG procured by national HIV programmes can cover 78% and 86% of people on #ART respectively.
✅ Azerbaijan is making strides to reach 65%of people on ART with DTG treatments this year🎉
✅Malaysia is planning to accelerate the transition to TLD starting from 2025.
These achievements were made possible by price reductions ↘️ of over 90% and are a result of the dedication of many, incl communities, healthcare professionals & governments.
Read our statement 👉 https://t.co/K4WGMquPSq
#GlobalHealth #Access2Meds
🌐 Discover the New #MedsPaL: Your trusted source for #EssentialMedicine💊🫗 and #Vaccine💉 patent information just got an upgrade!
🚀 Explore the latest features like 👇🏾
✅saved searches 💾,
✅email notifications 📧, and
✅enhanced mobile compatibility 📱.
Stay ahead in the IP landscape with https://t.co/a7tSHEW5M6
🗞️#PressRelease | 🎉The Medicines Patent Pool Unveils New Version🚀 of #MedsPaL 💻for Streamlined Access to #GlobalHealth#IntellectualProperty Information.
Access our PR 👉🏾https://t.co/31gobEtJhx
🔎#MedsPaL is a free resource that provides crucial information on the intellectual property status of
✅patented essential medicines,
✅COVID-19 vaccines, and
✅long-acting platform technologies,
with a particular focus on low- and middle-income countries🌍.
As we reflect on a decade of collaboration w/ ViiV Healthcare, we are proud to see that #PublicHealth-oriented voluntary licensing has had tangible impact in the lives of the people we serve, enabling access to affordable versions of innovative #HIV treatments in LMICs.
🗞️#PressRelease|Transformative partnership between @MedsPatentPool and ViiV Healthcare enables 2⃣4⃣ million people in low- and middle-income countries🗺️ to access innovative #HIV treatment.
Today we celebrate the 🔟-year anniversary of the MPP-ViiV public health-oriented voluntary licence agreements on #dolutegravir.
Read our joint press release 👉🏾 https://t.co/PmUkjNLuar
#PublicHealth #GlobalHealth #Access2Meds #HealthForAll
🎙️@CharlieGore du MPP explique ce qu’est le programme de transfert de technologies à ARN messager qui comprend 6️⃣ partenaires en #Afrique.
✅accès équitable aux technologies à ARNm
✅Valeur ajoutée et partage des actifs de propriété intellectuelle
✅Capacités de production durables de vaccins à ARNm
🙌🏽 La production régionale en Afrique est essentielle pour l’autonomie de l’Afrique
https://t.co/wnSYiLIEWG
La session “renforcer l’écosystème de la production régionale et locale en #Afrique de l’Ouest et Centrale” commence à l’@IFCameroun.
✅Nous allons aborder le programme de transfer de technologies #ARNm avec 6️⃣partenaires en Afrique
✅Nous discuterons aussi des initiatives d’@UNITAID pour promouvoir la production régionale
✅ Nous explorerons comment le #Cameroun peut devenir un modèle dans ce domaine
#AFRAVIH2024 au Symposium d’@UNITAID
🎙️Le Directeur exécutif du MPP @CharlieGore explique comment le modèle du MPP, qui a été créé par @UNITAID, participe à la réponse contre le #VIH aux côtés de nombreux autres partenaires.
🤝Le MPP a notamment signé une licence avec @ViiVHC pour le #dolutegravir ce qui permet un accès abordable de ce produit, recommandé en 1ere intention par @WHO, dans les pays à revenus faible et intermédiaire.
👉🏽https://t.co/CAliEwwG10
Vous êtes à #AFRAVIH2024 au #Cameroun 🇨🇲?
Notre directeur exécutif @CharlieGore participera au symposium d’@UNITAID cet après-midi à 15h30, salle 4/E.
Il expliquera comment le Medicines Patent Pool a contribué à la lutte contre le #VIH et ses co-infections.
Venez nombreux !
Earlier today MPP ED @CharlieGore participated in a panel discussion on "Elimination of viral hepatitis: What still needs to be done to make it real?" during the #WorldHepatitisSummit 👇🏾
✅Access to affordable #hepatitis testing and treatment should be available to all, including in low- and middle-income countries
✅if countries do not procure medicines at the access price, the price may not be guaranteed anymore > investment cases are needed!
✅MPP welcomes the newly released @WHO 2024 Global #Hepatitis report > https://t.co/emFNQuPYSL